Spark Therapeutics
A fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€3.9b (Public information from Feb 2019)
Philadelphia Pennsylvania (HQ)
Authorizing premium user...